Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Small Cell Lung Cancer × Cisplatin × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 484 Lung Neoplasms 220 Small Cell Lung Carcinoma 95 Mesothelioma, Malignant 54 Adenocarcinoma of Lung 37 Mesothelioma 30 Neoplasms 26 Colorectal Neoplasms 21 Neoplasm Metastasis 19 Ovarian Neoplasms 15 Carcinoma 15 Squamous Cell Carcinoma of Head and Neck 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Pancreatic Neoplasms 12 Adenocarcinoma, Bronchiolo-Alveolar 12 Non-Squamous Non-Small Cell Lung Cancer 11 Stomach Neoplasms 10 Head and Neck Neoplasms 10 Pleural Effusion, Malignant 8 Melanoma 7 Extensive Stage Small Cell Lung Cancer 7 Breast Neoplasms 7 Thymoma 6 Solitary Fibrous Tumor, Pleural 6 Sarcoma 6 Drug-Related Side Effects and Adverse Reactions 6 Colonic Neoplasms 6 Carcinoma, Small Cell 6 Carcinoma, Ovarian Epithelial 6 Adenocarcinoma 6

Interventions

Etoposide 2 Carboplatin 2 anlotinib 1 Radiotherapy 1 Drug Therapy 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07083375 2025-07-24

QL1706

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Extensive Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡